Association of Endocrine Therapy With Overall Survival in Women With Small, Hormone Receptor-Positive, ERBB2-Negative Breast Cancer.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 32833014.
- Also identified by DOI 10.1001/jamanetworkopen.2020.13973 and PMC identifier 7445593.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This cohort study examines the association of overall survival with endocrine therapy to treat hormone receptor–positive, <i>ERBB2</i>-negative breast cancer.
Medical subject headings
- Antineoplastic Agents, Hormonal
- Breast Neoplasms